Skip to main content
Premium Trial:

Request an Annual Quote

NSF Issues Three New SBIR Grants

NEW YORK, June 19 - The National Science Foundation last week announced several new Phase I SBIR awards that will support technology development in genomics and microarray science.

 

On June 11, the science agency announced it would grant $99,873 to US Genomics to help it improve and fine-tune its Gene Engine genomic analysis technology. With the grant, US Genomics, of Woburn, Mass., will design fluorescent sequence-specific tags, develop new methods to attach the tags to DNA targets, improve microfluidic systems, and test the system with DNA fragments up to 200 kilobases long.

 

NSF also has awarded $99,700 to Parallel Synthesis Technologies, which is developing microfabrication techniques to create new silicon spotting pins for microarrays. Using silicon instead of metal to create spots could improve uniformity, lower cost, and increase spot density, according to the Menlo Park, Calif. company. This award was granted on June 11 as well.

 

On June 13, NSF announced a $100,000 grant to Prediction Sciences, a small San Diego software company that is working to develop a platform to analyze the pharmacogenomics of depression treatment with citalopram (Celexa).

 

All three grants are slated to begin on July 1.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.